ARGENX BV
502091-8545ActiveEngineering life-changing immunology solutions for severe autoimmune diseases.
Översikt
- 1–4
- Anställda
- Okänt
- Omsättning
- 2022
- Grundat
Nyckelbeslutsfattare
Dr. Pamela M. Klein
Non-executive Director
Wim Parys
Strategic Advisor to the R&D Committee
Dr. Ana Cespedes
Non-executive Director, Chairperson of the Remuneration & Nomination Committee
Peter Ulrichts
Chief Scientific Officer
+23 fler kontakter i Funnelfeedr
Beskrivning
argenx is a global immunology company dedicated to engineering life-changing therapeutic antibodies. They operate an advanced antibody innovation ecosystem where pioneering scientists collaborate closely with engineers. This structure accelerates the discovery of novel targets and differentiated the...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- Utländsk juridisk person
- Momsnummer
- SE502091854501
Beslutsfattare
27 kontakter i FunnelfeedrDr. Pamela M. Klein
Non-executive Director
Wim Parys
Strategic Advisor to the R&D Committee
Dr. Ana Cespedes
Non-executive Director, Chairperson of the Remuneration & Nomination Committee
Peter Ulrichts
Chief Scientific Officer
Camilla Sylvest
Non-executive Director
Filip Borgions
Chief Technology Innovation Officer
Karl Gubitz
Chief Financial Officer
Hans de Haard
Co-Founder, Strategic Advisor to the R&D Committee
Karen Massey
Chief Executive Officer, Executive Director of the Board of Directors
Luc Truyen
Chief Medical Officer
Mary Lynne Hedley
Strategic Advisor to the R&D Committee
Dr. Brian Kotzin
Non-executive Director and Chairperson of the R&D Committee
Marc Schorpion
Global Head of Human Resources
Achim Plueckebaum
Global Head of Digital Technologies
Sandrine Piret‑Gerard
Chief Commercialization Officer
Steve Krognes
Non-executive Director, Chairperson of the Audit and Compliance Committee, Member of the Remuneration & Nomination Committee
An Vandebosch
Head of Development
Tim Van Hauwermeiren
Co-Founder, Non-Independent Non-Executive Director and Chairperson of the Board
Tony Rosenberg
Non-executive Director, Vice Chairperson of the Board
David L. Lacey
Strategic Advisor to the R&D Committee
Malini Moorthy
General Counsel
Beth DelGiacco
Corporate Affairs
Andria Wilk
Global Head of Quality
Övriga kontakter
Lynn Elton
Investor Relations (EU)
Erin Murphy
Media Relations
Alexandra Roy
Investor Relations (US)
Arjen Lemmen
Corporate Development & Strategy
Liknande företag
20 liknande företag i FunnelfeedrAAX Biotech AB
5–9 anställdaResearch-driven biotech advancing antibody therapies via proprietary technology.
ULTRAGENYX EUROPE GMBH
1–4 anställdaAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Oblique Therapeutics AB (publ)
10–19 anställdaInnovative biotech developing breakthrough antibodies using the AbiProt platform.
AMICUS THERAPEUTICS LTD
1–4 anställdaGlobal biotechnology company developing transformative medicines for rare diseases.
Alexion Pharma Nordics AB
10–19 anställdaPioneering transformative medicines for the global rare disease community.
Frågor om ARGENX BV
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo